BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35075370)

  • 21. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
    Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
    FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma.
    Li M; Jin X; Guo F; Wu G; Wu L; Deng S
    J Cell Biochem; 2019 Sep; 120(9):15397-15409. PubMed ID: 31037778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential crucial genes and key pathways in osteosarcoma.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics Analysis Identifies Hub Genes and Molecular Pathways Involved in Sepsis-Induced Myopathy.
    Ning YL; Yang ZQ; Xian SX; Lin JZ; Lin XF; Chen WT
    Med Sci Monit; 2020 Feb; 26():e919665. PubMed ID: 32008037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.
    Xie B; Li Y; Zhao R; Xu Y; Wu Y; Wang J; Xia D; Han W; Chen D
    Biomed Res Int; 2018; 2018():4761064. PubMed ID: 29850522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.
    Guan D; Tian H
    World J Surg Oncol; 2017 Sep; 15(1):177. PubMed ID: 28934958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
    Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
    Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
    Guo T; Hou D; Yu D
    Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
    Liu J; Li J; Li H; Li A; Liu B; Han L
    Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
    DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key genes in osteosarcoma - before and after CDK7 treatment.
    An Y; Wang Y; Xu G; Liao Y; Huang G; Jin X; Xie C; Li Q; Yin D
    Medicine (Baltimore); 2021 Oct; 100(39):e27304. PubMed ID: 34596127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
    Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
    Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant Prostate Cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
    Zheng L; Dou X; Ma X; Qu W; Tang X
    Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of hub genes in rheumatoid arthritis through an integrated bioinformatics approach.
    Wu R; Long L; Zhou Q; Su J; Su W; Zhu J
    J Orthop Surg Res; 2021 Jul; 16(1):458. PubMed ID: 34271942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.